Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma

Despite a general role for the HIF hydroxylase system in cellular oxygen sensing and tumour hypoxia, cancer-associated mutations of genes in this pathway, including PHD2, PHD1, EPAS1 (encoding HIF-2α) are highly tissue-restricted, being observed in pseudohypoxic pheochromocytoma and paraganglioma (P...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eckardt, Luise (VerfasserIn) , Prange-Barczynska, Maria (VerfasserIn) , Hodson, Emma J. (VerfasserIn) , Fielding, James W. (VerfasserIn) , Cheng, Xiaotong (VerfasserIn) , Lima, Joanna D. C. C. (VerfasserIn) , Kurlekar, Samvid (VerfasserIn) , Douglas, Gillian (VerfasserIn) , Ratcliffe, Peter J. (VerfasserIn) , Bishop, Tammie (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 September 2021
In: Endocrine related cancer
Year: 2021, Jahrgang: 28, Heft: 12, Pages: 757-772
ISSN:1479-6821
DOI:10.1530/ERC-21-0211
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1530/ERC-21-0211
Verlag, lizenzpflichtig, Volltext: https://erc.bioscientifica.com/view/journals/erc/28/12/ERC-21-0211.xml
Volltext
Verfasserangaben:Luise Eckardt, Maria Prange-Barczynska, Emma J. Hodson, James W. Fielding, Xiaotong Cheng, Joanna D.C.C. Lima, Samvid Kurlekar, Gillian Douglas, Peter J. Ratcliffe and Tammie Bishop

MARC

LEADER 00000caa a2200000 c 4500
001 1816774766
003 DE-627
005 20230118162149.0
007 cr uuu---uuuuu
008 220916s2021 xx |||||o 00| ||eng c
024 7 |a 10.1530/ERC-21-0211  |2 doi 
035 |a (DE-627)1816774766 
035 |a (DE-599)KXP1816774766 
035 |a (OCoLC)1361714217 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eckardt, Luise  |e VerfasserIn  |0 (DE-588)1265524858  |0 (DE-627)1814413464  |4 aut 
245 1 0 |a Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma  |c Luise Eckardt, Maria Prange-Barczynska, Emma J. Hodson, James W. Fielding, Xiaotong Cheng, Joanna D.C.C. Lima, Samvid Kurlekar, Gillian Douglas, Peter J. Ratcliffe and Tammie Bishop 
264 1 |c 20 September 2021 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.09.2022 
520 |a Despite a general role for the HIF hydroxylase system in cellular oxygen sensing and tumour hypoxia, cancer-associated mutations of genes in this pathway, including PHD2, PHD1, EPAS1 (encoding HIF-2α) are highly tissue-restricted, being observed in pseudohypoxic pheochromocytoma and paraganglioma (PPGL) but rarely, if ever, in other tumours. In an effort to understand that paradox and gain insights into the pathogenesis of pseudohypoxic PPGL, we constructed mice in which the principal HIF prolyl hydroxylase, Phd2, is inactivated in the adrenal medulla using TH-restricted Cre recombinase. Investigation of these animals revealed a gene expression pattern closely mimicking that of pseudohypoxic PPGL. Spatially resolved analyses demonstrated a binary distribution of two contrasting patterns of gene expression among adrenal medullary cells. Phd2 inactivation resulted in a marked shift in this distribution towards a Pnmt−/Hif-2α+/Rgs5+ population. This was associated with morphological abnormalities of adrenal development, including ectopic TH+ cells within the adrenal cortex and external to the adrenal gland. These changes were ablated by combined inactivation of Phd2 with Hif-2α, but not Hif-1α. However, they could not be reproduced by inactivation of Phd2 in adult life, suggesting that they arise from dysregulation of this pathway during adrenal development. Together with the clinical observation that pseudohypoxic PPGL manifests remarkably high heritability, our findings suggest that this type of tumour likely arises from dysregulation of a tissue-restricted action of the PHD2/HIF-2α pathway affecting adrenal development in early life and provides a model for the study of the relevant processes. 
700 1 |a Prange-Barczynska, Maria  |e VerfasserIn  |4 aut 
700 1 |a Hodson, Emma J.  |e VerfasserIn  |4 aut 
700 1 |a Fielding, James W.  |e VerfasserIn  |4 aut 
700 1 |a Cheng, Xiaotong  |e VerfasserIn  |4 aut 
700 1 |a Lima, Joanna D. C. C.  |e VerfasserIn  |4 aut 
700 1 |a Kurlekar, Samvid  |e VerfasserIn  |4 aut 
700 1 |a Douglas, Gillian  |e VerfasserIn  |4 aut 
700 1 |a Ratcliffe, Peter J.  |e VerfasserIn  |4 aut 
700 1 |a Bishop, Tammie  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Endocrine related cancer  |d Bristol : Soc. for Endocrinology, 1994  |g 28(2021), 12, Seite 757-772  |h Online-Ressource  |w (DE-627)312182570  |w (DE-600)2010895-3  |w (DE-576)281192685  |x 1479-6821  |7 nnas  |a Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma 
773 1 8 |g volume:28  |g year:2021  |g number:12  |g pages:757-772  |g extent:16  |a Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma 
856 4 0 |u https://doi.org/10.1530/ERC-21-0211  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://erc.bioscientifica.com/view/journals/erc/28/12/ERC-21-0211.xml  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220916 
993 |a Article 
994 |a 2021 
998 |g 1265524858  |a Eckardt, Luise  |m 1265524858:Eckardt, Luise  |d 50000  |e 50000PE1265524858  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1816774766  |e 4189290696 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 16.09.2022"],"recId":"1816774766","language":["eng"],"person":[{"roleDisplay":"VerfasserIn","display":"Eckardt, Luise","role":"aut","family":"Eckardt","given":"Luise"},{"roleDisplay":"VerfasserIn","display":"Prange-Barczynska, Maria","role":"aut","family":"Prange-Barczynska","given":"Maria"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hodson, Emma J.","given":"Emma J.","family":"Hodson"},{"family":"Fielding","given":"James W.","display":"Fielding, James W.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Cheng","given":"Xiaotong","display":"Cheng, Xiaotong","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Lima, Joanna D. C. C.","role":"aut","family":"Lima","given":"Joanna D. C. C."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kurlekar, Samvid","given":"Samvid","family":"Kurlekar"},{"display":"Douglas, Gillian","roleDisplay":"VerfasserIn","role":"aut","family":"Douglas","given":"Gillian"},{"family":"Ratcliffe","given":"Peter J.","roleDisplay":"VerfasserIn","display":"Ratcliffe, Peter J.","role":"aut"},{"role":"aut","display":"Bishop, Tammie","roleDisplay":"VerfasserIn","given":"Tammie","family":"Bishop"}],"title":[{"title_sort":"Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma","title":"Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma"}],"physDesc":[{"extent":"16 S."}],"relHost":[{"language":["eng"],"recId":"312182570","disp":"Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytomaEndocrine related cancer","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 30.09.2025"],"titleAlt":[{"title":"Endocrine-related cancer"}],"part":{"extent":"16","volume":"28","text":"28(2021), 12, Seite 757-772","issue":"12","pages":"757-772","year":"2021"},"pubHistory":["1.1994 -"],"title":[{"title_sort":"Endocrine related cancer","title":"Endocrine related cancer","subtitle":"a Society for Endocrinology publication"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1479-6821"],"zdb":["2010895-3"],"eki":["312182570"]},"origin":[{"dateIssuedKey":"1994","publisher":"Soc. for Endocrinology","dateIssuedDisp":"1994-","publisherPlace":"Bristol"}]}],"name":{"displayForm":["Luise Eckardt, Maria Prange-Barczynska, Emma J. Hodson, James W. Fielding, Xiaotong Cheng, Joanna D.C.C. Lima, Samvid Kurlekar, Gillian Douglas, Peter J. Ratcliffe and Tammie Bishop"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"20 September 2021"}],"id":{"eki":["1816774766"],"doi":["10.1530/ERC-21-0211"]}} 
SRT |a ECKARDTLUIDEVELOPMEN2020